HUMAN AMYLIN ANALOG POLYPEPTIDES AND METHODS OF USE

Number of patents in Portfolio can not be more than 2000

United States of America

APP PUB NO 20240417438A1
SERIAL NO

18661201

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention relates to isolated polypeptides that are analogs of human amylin. The disclosed amylin analog polypeptides have beneficial physicochemical properties relative to endogenous amylin, such as longer elimination half-lives (t1/2) and improved solubility and thermal stability. This invention also relates to methods of using presently disclosed amylin analog polypeptides in a variety of therapeutic indications, as well as methods of producing the same. The disclosed amylin analog polypeptides are particularly useful in methods of treating metabolic diseases or disorders, such as types 1 and 2 diabetes, and providing weight loss.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
I2O THERAPEUTICS INCCAMBRIDGE MA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Blackwell, William Cambridge, US 15 50
Srivastava, Ved P Cambridge, US 14 39
Way, James M Cambridge, US 6 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation